Trends in Systemic Inflammatory Reaction (SIR) during Paclitaxel and Carboplatin Chemotherapy in Women Suffering from Epithelial Ovarian Cancer.

MLA

Mleko, Michal, et al. “Trends in Systemic Inflammatory Reaction (SIR) during Paclitaxel and Carboplatin Chemotherapy in Women Suffering from Epithelial Ovarian Cancer.” Cancers, vol. 15, no. 14, July 2023, p. 3607. EBSCOhost, https://doi.org/10.3390/cancers15143607.

APA

Mleko, M., Pluta, E., Pitynski, K., Bodzek, M., Kałamacki, A., Kiprian, D., & Banas, T. (2023). Trends in Systemic Inflammatory Reaction (SIR) during Paclitaxel and Carboplatin Chemotherapy in Women Suffering from Epithelial Ovarian Cancer. Cancers, 15(14), 3607. https://doi.org/10.3390/cancers15143607

Chicago

Mleko, Michal, Elzbieta Pluta, Kazimierz Pitynski, Maciej Bodzek, Andrzej Kałamacki, Dorota Kiprian, and Tomasz Banas. 2023. “Trends in Systemic Inflammatory Reaction (SIR) during Paclitaxel and Carboplatin Chemotherapy in Women Suffering from Epithelial Ovarian Cancer.” Cancers 15 (14): 3607. doi:10.3390/cancers15143607.